uric acid has been researched along with levodopa in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (20.83) | 18.7374 |
| 1990's | 3 (12.50) | 18.2507 |
| 2000's | 4 (16.67) | 29.6817 |
| 2010's | 7 (29.17) | 24.3611 |
| 2020's | 5 (20.83) | 2.80 |
| Authors | Studies |
|---|---|
| Babucke, G; Mertz, DP; Sagebiel, L | 1 |
| Kelley, WN | 1 |
| Nishizawa, T | 1 |
| Bierer, DW; Quebbemann, AJ | 2 |
| Carey, RJ; Dai, H; Huston, JP; Pinheiro-Carrera, M; Tomaz, C | 1 |
| Farhan Asad, S; Hadi, SM; Singh, S | 1 |
| Akiyama, A; Nakazato, T | 1 |
| Delogu, MR; Desole, MS; Enrico, P; Esposito, G; Grella, G; Miele, E; Miele, M; Migheli, R; Mura, MA; Serra, PA | 1 |
| Abreu, P; Gonzalez, MC; Sanchez, JJ | 1 |
| Annanmaki, T; Murros, K; Muuronen, A | 1 |
| Andreadou, E; Boufidou, F; Gournaras, F; Nikolaou, C; Rentzos, M; Tsoutsou, A; Vassilopoulos, D; Zissimopoulos, V; Zournas, C | 1 |
| Chao, L; Chen, C; Dai, M; Huang, T; Meng, W; Tan, Y; Xie, Q | 1 |
| Altunkaynak, Y; Baybas, S; Dirican, AC; Köksal, A; Mutluay, B; Vieru, E | 1 |
| Ghodsi, J; Rafati, AA; Shoja, Y | 1 |
| Ensafi, AA; Havakeshian, E; Rezaei, B; Shams-Ghahfarokhi, L | 1 |
| Arivanandhan, M; Hayakawa, Y; Kanchana, P; Navaneethan, M; Radhakrishnan, S; Sekar, C | 1 |
| Gao, X; Guan, E; Guo, E; Huang, S; Li, B; Lin, X; Song, S; Wang, B; Wu, P; Yue, H; Zhang, H | 1 |
| Hassanvand, Z; Jalali, F | 1 |
| Baik, K; Chung, SJ; Jung, JH; Lee, PH; Lee, YH; Sohn, YH; Ye, BS; Yoo, HS | 1 |
| Baik, JS; Lee, JJ | 1 |
| Chan, J; Goetz, CG; Luo, S; Macklin, EA; Oakes, D; Schwarzschild, MA; Simuni, T; Stebbins, GT; Zou, H | 1 |
| Cibulka, M; Cierny, D; Grendar, M; Grofik, M; Kolisek, M; Kurca, E; Nosal, V; Oleksakova, J; Ruzinak, R; Sivak, S; Tatarkova, Z | 1 |
| Almeida, RMM; Artigas, NR; Dutra, ACL; Krimberg, JS; Monticelli, BE; Pereira, GM; Rieder, CRM; Schumacher-Schuh, AF; Soares, NM | 1 |
1 review(s) available for uric acid and levodopa
| Article | Year |
|---|---|
Effects of drugs on uric acid in man.
Topics: Antineoplastic Agents; Depression, Chemical; Diuretics; Ethambutol; Ethanol; Fructose; Humans; Levodopa; Nicotinic Acids; Pyrazinamide; Salicylates; Thiadiazoles; Uric Acid; Uricosuric Agents | 1975 |
23 other study(ies) available for uric acid and levodopa
| Article | Year |
|---|---|
[Hyperuricemia in Parkinson's syndrome--by chance or probable?].
Topics: Adult; Aged; Female; Gout; Humans; Hypertension; Levodopa; Male; Middle Aged; Obesity; Parkinson Disease, Secondary; Sex Factors; Uric Acid | 1976 |
[Secondary hyperuricemia].
Topics: Cardiovascular Diseases; Diuretics; Endocrine System Diseases; Ethanol; Fructose; Gout; Hematologic Diseases; Humans; Levodopa; Nutritional Physiological Phenomena; Proteins; Purines; Uric Acid; Urologic Diseases | 1985 |
Effect of L-dopa on renal handling of uric acid.
Topics: Animals; Biological Transport; Chickens; Kidney Tubules; Levodopa; Metabolic Clearance Rate; Uric Acid | 1982 |
Interference of levodopa and its metabolites with colorimetry of uric acid.
Topics: 3,4-Dihydroxyphenylacetic Acid; Colorimetry; Dopamine; Homovanillic Acid; Humans; Levodopa; Parkinson Disease; Uric Acid | 1981 |
L-dopa induced increases in brain uric acid in an animal model of Parkinson's disease: a relationship to behavioral activation.
Topics: Animals; Behavior, Animal; Brain; Disease Models, Animal; Dopamine; Levodopa; Male; Neurons; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Substantia Nigra; Sympathectomy, Chemical; Uric Acid; Ventral Tegmental Area | 1994 |
Uric acid inhibits L-DOPA-CU(II) mediated DNA cleavage.
Topics: Animals; Cattle; Chromosome Breakage; Copper; DNA; DNA Damage; DNA, Superhelical; Dose-Response Relationship, Drug; Hydroxyl Radical; Levodopa; Mannitol; Oxidation-Reduction; Plasmids; Thiourea; Uric Acid; Xanthine | 1998 |
High-speed voltammetry: dual measurement of dopamine and serotonin.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Animals; Dopamine; Dopamine Agents; Electrochemistry; Hydroxyindoleacetic Acid; Ion-Selective Electrodes; Levodopa; Male; Potentiometry; Rats; Rats, Wistar; Serotonin; Uric Acid | 1999 |
Manganese increases L-DOPA auto-oxidation in the striatum of the freely moving rat: potential implications to L-DOPA long-term therapy of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcysteine; Animals; Ascorbic Acid; Chlorides; Chromatography, High Pressure Liquid; Corpus Striatum; Dialysis Solutions; Dopamine; Homovanillic Acid; Infusion Pumps; Levodopa; Male; Manganese; Manganese Compounds; Microdialysis; Movement; Oxidation-Reduction; Parkinson Disease; Rats; Rats, Wistar; Time Factors; Uric Acid | 2000 |
Sodium nitroprusside stimulates L-DOPA release from striatal tissue through nitric oxide and cGMP.
Topics: Animals; Corpus Striatum; Cyclic GMP; Dose-Response Relationship, Drug; Levodopa; Male; Melatonin; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Oxadiazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Salicylic Acid; Superoxide Dismutase; Uric Acid | 2002 |
Low plasma uric acid level in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Body Mass Index; Energy Intake; Female; Ferritins; Humans; Levodopa; Male; Mass Screening; Middle Aged; Parkinson Disease; Plasma; Risk Factors; Selegiline; Spouses; Uric Acid | 2007 |
Serum uric acid levels in patients with Parkinson's disease: their relationship to treatment and disease duration.
Topics: Aged; Antiparkinson Agents; Body Mass Index; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Uric Acid | 2009 |
Horseradish peroxidase-catalyzed polymerization of L-DOPA for mono-/bi-enzyme immobilization and amperometric biosensing of H2O2 and uric acid.
Topics: Biosensing Techniques; Catalysis; Chitosan; Electrodes; Enzymes, Immobilized; Gold; Horseradish Peroxidase; Humans; Hydrogen Peroxide; Levodopa; Polymerization; Urate Oxidase; Uric Acid | 2016 |
The relation of serum uric acid levels with L-Dopa treatment and progression in patients with Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Case-Control Studies; Disease Progression; Female; Humans; Levodopa; Logistic Models; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Statistics, Nonparametric; Uric Acid | 2016 |
First report on hemoglobin electrostatic immobilization on WO3 nanoparticles: application in the simultaneous determination of levodopa, uric acid, and folic acid.
Topics: Animals; Biosensing Techniques; Cattle; Folic Acid; Hemoglobins; Isoelectric Point; Levodopa; Metal Nanoparticles; Oxides; Static Electricity; Tungsten; Uric Acid | 2016 |
An electrochemical biosensor based on nanoporous stainless steel modified by gold and palladium nanoparticles for simultaneous determination of levodopa and uric acid.
Topics: Biosensing Techniques; Electrochemical Techniques; Gold; Humans; Levodopa; Metal Nanoparticles; Nanopores; Palladium; Stainless Steel; Tablets; Uric Acid | 2016 |
Electrochemical Sensor Based on Fe Doped Hydroxyapatite-Carbon Nanotubes Composite for L-Dopa Detection in the Presence of Uric Acid.
Topics: Catalysis; Durapatite; Electrochemistry; Electrodes; Glass; Iron; Levodopa; Limit of Detection; Mucuna; Nanotubes, Carbon; Oxidation-Reduction; Uric Acid | 2016 |
3-Dimensional hollow graphene balls for voltammetric sensing of levodopa in the presence of uric acid.
Topics: Electrochemical Techniques; Electrodes; Graphite; Humans; Levodopa; Metal Nanoparticles; Nickel; Parkinson Disease; Tin Compounds; Uric Acid | 2018 |
Simultaneous determination of l‑DOPA, l‑tyrosine and uric acid by cysteic acid - modified glassy carbon electrode.
Topics: Carbon; Cysteic Acid; Electrochemical Techniques; Electrodes; Glass; Humans; Hydrogen-Ion Concentration; Levodopa; Polymerization; Tyrosine; Uric Acid | 2019 |
Sex-specific association of urate and levodopa-induced dyskinesia in Parkinson's disease.
Topics: Antiparkinson Agents; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Parkinson Disease; Uric Acid | 2020 |
Peripheral Neuropathy in
Topics: Adult; Aged; Case-Control Studies; Female; Homocysteine; Humans; Levodopa; Male; Middle Aged; Neural Conduction; Parkinson Disease; Peripheral Nervous System Diseases; Prevalence; Risk Factors; Uric Acid; Vitamin B 12 | 2020 |
Dissecting the Domains of Parkinson's Disease: Insights from Longitudinal Item Response Theory Modeling.
Topics: Bayes Theorem; Humans; Inosine; Levodopa; Parkinson Disease; Severity of Illness Index; Tremor; Uric Acid | 2022 |
Oxidative stress parameters and their relation to motor subtype of Parkinson's disease and levodopa treatment status.
Topics: Antioxidants; Female; Glutathione; Humans; Levodopa; Oxidative Stress; Parkinson Disease; Uric Acid | 2023 |
Low serum uric acid levels and levodopa-induced dyskinesia in Parkinson's disease.
Topics: Antiparkinson Agents; Dyskinesias; Female; Humans; Levodopa; Male; Parkinson Disease; Uric Acid | 2023 |